Skip to main content
| News

Basel is evolving into a pediatrics hub

18.12.2019

The Botnar Research Center for Child Health in Basel has started its research activities. The first four projects have now been selected. Together with the DayOne Accelerator from BaselArea.swiss, Basel is gradually evolving into a pediatrics hub.

Children should benefit from research in Basel (img: Creative Commons)

The Botnar Research Center for Child Health (BRCCH) aims to foster novel and innovative research in pediatrics, a field in which the center benefits from partnerships with the University of Basel, the University Children’s Hospital Basel, the Swiss Tropical and Public Health Institute (Swiss TPH) and the Federal Institute of Technology in Zurich (ETH), according to a statement. On January 30, 2020, the BRCCH is hosting its first Spotlight Day in Basel, where it will showcase the four research projects that are kickstarting the center’s activities.

One project features an app with a digital medical system that can support the wellbeing of infants and young children growing up in rural areas of low-and middle-income countries. The platform is being assessed via a study of 2,400 children in Peru. Children with cleft lip or palate are the focus of the second project, which seeks to optimize surgical treatment with the use of artificial intelligence, smartphone-based images and 3D-printing of orthopedic plates.

For the third project, researchers are examining gut floral to fight infection and inflammatory disease in children. Using a CRISPR-based technology, they aim to develop bacteria that will provide assessments of the gut to improve the health of affected children. Gut bacteria are also the focus of the fourth project, which plans to replace “bad” bacteria with useful bacteria. This modification will be achieved with the help of engineered antibodies, and the direct targeting of individual genes in intestine-resident bacteria by employing CRISPR-Cas9 methodology.

The research activities at the BRCCH cement Basel’s growing reputation as a pediatrics hub. The city’s location promotion organization BaselArea.swiss is also using its DayOne Accelerator to support Digital Health startups that are working to improve the health of children and young people. Participants for the second round were recently announced.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area Business & Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Read More
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
1 2 3 35

Do you have a question? We'd like to hear from you.